Advisory Research’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4M	Sell	10,981 -288	-3%	-$36K	0.17%	94
2025 Q4	$1.37M	Buy	11,269 +586	+5%	+$67.2K	0.17%	91
2025 Q3	$1.07M	Buy	10,683 +406	+4%	+$36.6K	0.14%	105
2025 Q2	$852K	Buy	10,277 +691	+7%	+$55.1K	0.13%	110
2025 Q1	$777K	Buy	9,586 +26	+0.3%	+$2.32K	0.14%	116
2024 Q4	$861K	Buy	9,560 +51	+0.5%	+$4.94K	0.14%	117
2024 Q3	$939K	Sell	9,509 -321	-3%	-$31.5K	0.17%	110
2024 Q2	$911K	Buy	9,830 +648	+7%	+$58.1K	0.17%	109
2024 Q1	$871K	Sell	9,182 -562	-6%	-$52.1K	0.17%	107
2023 Q4	$870K	Sell	9,744 -526	-5%	-$39.1K	0.13%	178
2023 Q3	$750K	Sell	10,270 -779	-7%	-$62.2K	0.1%	224
2023 Q2	$919K	Buy	11,049 +3,244	+42%	+$271K	0.12%	214
2023 Q1	$595K	Sell	7,805 -148	-2%	-$12.3K	0.1%	227
2022 Q4	$660K	Sell	7,953 -8	-0.1%	-$648	0.06%	216
2022 Q3	$631K	Buy	+7,961	New	+$671K	0.06%	211